GlassScriptPhysician profile
Kevin P Marzo
NPI 1376539817
$1,653.48
in general payments reported to CMS, 2019-2025
16 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $24.12 · 2021: $135 · 2022: $155 · 2023: $330 · 2024: $604 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $338.52 | 2019-2023 | Optis, Mitraclip |
| Medtronic, INC. | $304.48 | 2021-2024 | Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $278.83 | 2024 | Watchman Flx, Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.19 | 2022-2025 | Lifevest |
| Pfizer INC. | $121.66 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $111.93 | 2022-2024 | Eliquis |
| Medtronic Vascular, INC. | $42.04 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $36.47 | 2021 | |
| Impulse Dynamics (USA) INC. | $36.17 | 2024 | Optimizer |
| Angiodynamics, INC. | $31.98 | 2023 | Alphavac |
| Actelion Pharmaceuticals US, INC. | $30.63 | 2024 | Opsumit, Uptravi |
| Heartflow, INC. | $25.72 | 2024 | |
| Teleflex LLC | $23.40 | 2025 | Chocolate |
| Novartis Pharmaceuticals Corporation | $22.52 | 2021 | |
| Cvrx, INC. | $10.94 | 2024 | Barostim Neo System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Marzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.